发明名称 |
Quinazoline based EGFR inhibitors |
摘要 |
The present invention relates to quinazoline containing zinc-binding moiety based derivatives of formula I that have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer.
|
申请公布号 |
US8349856(B2) |
申请公布日期 |
2013.01.08 |
申请号 |
US201113155788 |
申请日期 |
2011.06.08 |
申请人 |
CURIS, INC.;QIAN CHANGGENG;CAI XIONG |
发明人 |
QIAN CHANGGENG;CAI XIONG |
分类号 |
A61K31/517 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|